Meridian Bioscience New Products Posted to GenomeWeb: Natera, Sema4, Meridian Bioscience, More Meridian Bioscience Fiscal Q3 Revenues Drop 25 Percent The company has seen reduced demand for reagents related to COVID-19 testing compared to record highs in 2020. Meridian Bioscience Fiscal Q3 Preliminary Revenues Drop 25 Percent The diagnostics segment was negatively impacted by supply chain issues with reagents causing back orders toward the end of the quarter. Meridian Bioscience Resubmits Revogene SARS-CoV-2 Test to FDA for EUA The company withdrew its application in February to conduct additional studies after receiving guidance from the FDA. New Products Posted to GenomeWeb: Centogene, Meridian Bioscience, Oxford Nanopore, More May 7, 2021 Meridian Bioscience Fiscal Q2 Revenues Up 49 Percent Apr 6, 2021 NIH RADx Program Awards $29.3M to Increase SARS-CoV-2 Testing Capacity Apr 1, 2021 GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock Feb 23, 2021 Meridian Withdraws Emergency Use Authorization Application to FDA for Coronavirus MDx Test Feb 16, 2021 Meridian Shares Drop as Much as 15 Percent on FDA Questions About SARS-CoV-2 Test Feb 5, 2021 Meridian Bioscience Fiscal Q1 Revenues Rise 96 Percent Feb 3, 2021 Meridian Bioscience Receives $5.5M From NIH to Expand SARS-CoV-2 Test Production Jan 7, 2021 Meridian Bioscience Preliminary Fiscal 2021 Q1 Revenues Up 94 Percent Dec 16, 2020 Meridian Bioscience Receives $1M NIH Grant for SARS-CoV-2 Test Launch Nov 13, 2020 Meridian Bioscience Q4 Revenues Climb 26 Percent, Beat Street Estimate Oct 26, 2020 Moving From Reagents Supplier to Test Developer, Meridian Bio Expands Role During COVID-19 Pandemic Premium Sep 1, 2020 Meridian Bioscience Leads Decliners in August as GenomeWeb Index Falls 4 Percent Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Aug 7, 2020 Meridian Bioscience Fiscal Q3 Revenues Soar 75 Percent on COVID-19-Related Life Sciences Growth Jul 2, 2020 Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020 Jul 1, 2020 Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index Jun 1, 2020 Fluidigm Leads May GenomeWeb Index on Early Detection SARS-Cov-2 Blood Test Collaboration Details May 22, 2020 People in the News: Tony Serafini-Lamanna, Martin Chavez, Sun Kim, Oved Amitay, More May 11, 2020 William Blair Upgrades Meridian Bioscience to Outperform May 8, 2020 Meridian Bioscience Posts 14 Percent Revenue Increase in Fiscal Q2, Raises FY2020 Guidance Load More Breaking News At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More FDA Grants Emergency Use Authorization for Northeastern University SARS-CoV-2 Test FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.